Posted 07 November, 2023

Nuburu, Inc. appointed Brian Knaley as new CEO

NYSE:BURU appointed new Chief Executive Officer Brian Knaley in a 8-K filed on 07 November, 2023.

  On November 1, 2023, Nuburu, Inc. (the "Company") appointed Brian Knaley as the Company's new Chief Executive Officer.  

Don't how to trade CEO change? Read Reasons for CEO Turnover and Effect on Stock Performance.
Overview of Nuburu, Inc.
Industrial Goods • Precision Products
Nuburu, Inc. focuses on bringing breakthrough improvements to a broad range of high value applications including welding and 3D printing. Its products, NUBURU AO and NUBURU BL series lasers, weld copper, aluminum, and dissimilar metals faster and better than any alternative approach. The company was founded by Mark S. Zediker and Jean-Michel Pelaprat in 2015 and is headquartered in Centennial, CO.
Market Cap
View Company Details
Relevant filing section
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of New Chief Executive Officer 

On November 1, 2023, Nuburu, Inc. (the "Company") appointed Brian Knaley as the Company's new Chief Executive Officer. Mr. Knaley, who had served as the Company's Chief Financial Officer since February 2022, has over 25 years of experience in finance and operations. Prior to joining NUBURU, Mr. Knaley served as the chief financial officer of CEA Industries Inc. (NASDAQ: CEAD), a provider of controlled environmental solutions, and as chief financial officer of Proximo Medical LLC, a start-up specializing in the commercialization of medical devices. He also served as senior vice president and interim chief financial officer of ViewRay (NASDAQ:VRAY), a global manufacturer of MRI-guided radiation therapy systems. Mr. Knaley holds a BA in Accounting from Thomas More College and is a licensed CPA in the State of Ohio. Mr. Knaley has also joined the Board of Directors of the Company. In connection with his appointment as Chief Executive Officer, Mr. Knaley will receive an annual base salary of $410,000 and 500,000 stock options that will vest over a four-year period, with 25% vesting on the first anniversary of the grant date and the remaining amount of the award vesting in equal monthly installments thereafter.

There is no arrangement or understanding between Mr. Knaley and any other person pursuant to which he was appointed as a director of the Company. Additionally, there is no transaction between Mr. Knaley and the Company that would require disclosure under Item 404(a) of Regulation S-K. 

Separation of Existing Chief Executive Officer

Mr. Knaley is replacing Mark Zediker who separated from service with the Company effective as of November 1, 2023. In connection with his separation, the Company and Dr. Zediker have entered into a Confidential Separation and Release Agreement, which provides for a cash severance payment of $200,000 and COBRA benefits for Dr. Zediker. The foregoing description of the Severance Agreement with Dr. Zediker is qualified in its entirety by reference to the full and complete text of such agreement, which will be filed as required.